# ReSure Sealant Post Approval Study

> **NCT02310815** · — · COMPLETED · sponsor: **Ocular Therapeutix, Inc.** · enrollment: 626 (actual)

## Conditions studied

- Adverse Events

## Interventions

- **DEVICE:** ReSure Sealant

## Key facts

- **NCT ID:** NCT02310815
- **Lead sponsor:** Ocular Therapeutix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-02
- **Final completion:** 2016-04
- **Target enrollment:** 626 (ACTUAL)
- **Last updated:** 2016-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02310815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02310815, "ReSure Sealant Post Approval Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02310815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*